Trial Profile
Comparison of the Prophylactic Anti-emetic Efficacy of Gabapentin and Ramosetron in Patients Undergoing Laparoscopic Gynecological Surgery
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 04 Nov 2017
Price :
$35
*
At a glance
- Drugs Gabapentin (Primary) ; Ramosetron (Primary)
- Indications Postoperative nausea and vomiting
- Focus Therapeutic Use
- 03 Dec 2015 New trial record